AI 摘要
我们查看了 herzuma 的 6 个实时结果，并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Oncology 和 Biosimilar。
Compare with TopFind
实时搜索
正在加载实时结果
TopFind 正在为你的搜索抓取最新匹配结果。
实时搜索
TopFind 正在为你的搜索抓取最新匹配结果。
我们查看了 herzuma 的 6 个实时结果，并筛选出最值得先比较的 3 个选项。
这份短名单里最突出的主题是 Oncology 和 Biosimilar。
来源: Celltrion Healthcare Singapore Private Limited
描述
Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies.
适用场景
HER2 Positive cancer care, Breast cancer patients 和 Affordable trastuzumab access
评分
来源: Celltrion Healthcare Philippines Inc.
描述
Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics.
适用场景
HER2 Positive cancer, Oncology therapy 和 Biosimilar oncology
评分
来源: Celltrion Healthcare
描述
Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials.
适用场景
HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy 和 Oncology infusion treatment
评分
| 比较 | Herzuma | Herzuma (Trastuzumab) | Herzuma (Trastuzumab) |
|---|---|---|---|
| 来源 | Celltrion Healthcare Singapore Private Limited | Celltrion Healthcare Philippines Inc. | Celltrion Healthcare |
| 描述 | Herzuma is a trastuzumab biosimilar referencing Herceptin, registered in Singapore for treating HER2-positive breast and gastric cancers. It provides a clinically comparable treatment option that is supported by local health subsidies. | Herzuma is a biosimilar used in the treatment of HER2-positive cancers, providing a high-quality alternative to reference biologics. | Herzuma is a biosimilar trastuzumab, a monoclonal antibody designed as a targeted oncology therapy for HER2-positive early breast cancer, metastatic breast cancer, and advanced gastric cancer. It is supplied as a powder for concentrate for solution for infusion in 150mg and 440mg vials. |
| 适用场景 | HER2 Positive cancer care, Breast cancer patients 和 Affordable trastuzumab access | HER2 Positive cancer, Oncology therapy 和 Biosimilar oncology | HER2 Positive breast cancer, Metastatic gastric cancer patients, Cost Effective targeted therapy 和 Oncology infusion treatment |
| 操作 | |||
| 评分 |
如果你想先看最均衡的选择，我推荐：
"Herzuma 来自 Celltrion Healthcare Singapore Private Limited."
我选择它是因为 Herzuma is a subsidy-eligible trastuzumab biosimilar that ensures affordability and accessibility for breast and gastric cancer patients in Singapore.